Log In
Print this Print this

Panaecin, gallium citrate

  Manage Alerts
Collapse Summary General Information
Company Aridis Pharmaceuticals Inc.
DescriptionSmall molecule anti-infective gallium compound
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPseudomonas
Indication DetailsTreat chronic lung infection due to Pseudomonas aeruginosa in cystic fibrosis (CF) patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today